Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Monster steal with assets of 0.16 $ per share and the new military contract. And this contract is just the start (see PR).
ECDC - TWITTER CEO coming on board with the acquisition of "Rogue Paper" - 8k is imminent. When it is filed, ECDC will literally explode.
ECDC - TWITTER CEO coming on board with the acquisition of "Rogue Paper" - 8k is imminent. When it is filed, ECDC will literally explode.
AFPW monster steal with 0.16 $ in assets and the new military contract.
AFPW monster steal with 0.16 $ in assets and the new military contract.
AFPW 70 mil $ assets
AFPW 70 mil $ assets
ECDC 8k is imminent, TWITTER CEO coming on board
ECDC 8k is imminent, TWITTER CEO coming on board
ECDC told u, monster in the making
AFPW dirt cheap
ECDC TWITTER CEO coming on board
AFPW 0.16 $ per share in assets
AFPW 0.16 $ per share in assets
AFPW told u - huge run has started. This thing will go to is real, asset-based value of 0.16 $ within a few weeks - and this number doesn"'t even include the new military contract (and many more are expected to follow after this "door-opening" contract from the US Army).
AFPW told u - huge run has started. This thing will go to is real, asset-based value of 0.16 $ within a few weeks - and this number doesn"'t even include the new military contract (and many more are expected to follow after this "door-opening" contract from the US Army).
AFPW fake wall there - this thing is on the verge of a missve run - no wonder with assets of 0.16 $ and a new military contract !!!!
AFPW fake wall there - this thing is on the verge of a missve run - no wonder with assets of 0.16 $ and a new military contract !!!!
AFPW buying pressure - 0.16 $ (!!!) in ASSETS (yes, it is for real) and the new military contract with many more to follow (see lastes PR).
AFPW buying pressure - 0.16 $ (!!!) in ASSETS (yes, it is for real) and the new military contract with many more to follow (see lastes PR).
AFPW massive breakout coming - this stock is soooo undervalued, rarely seen anything like this.
AFPW massive breakout coming - this stock is soooo undervalued, rarely seen anything like this.
AFPW massive breakout coming - this stock is soooo undervalued, rarely seen anything like this.
AFPW going - heavy buying coming in - and Here is WHY:
AFPW about to break out - with assets of 70 mil $ or 0.16 $ per share and a new military contract, it is one of the most undervalued stocks out there.
AFPW going - heavy buying coming in - and Here is WHY:
AFPW about to break out - with assets of 70 mil $ or 0.16 $ per share and a new military contract, it is one of the most undervalued stocks out there.
AFPW about to break out - with assets of 70 mil $ or 0.16 $ per share and a new military contract, it is one of the most undervalued stocks out there.
AFPW about to break out - with assets of 70 mil $ or 0.16 $ per share and a new military contract, it is one of the most undervalued stocks out there.
AFPW - wake up, folks - assets of 0.16 $ (YES, 0.16 $) and a new military contract with is very likely to be followed by more contracts, even from NATO.
PVCT - MUST read (cancer drug):
Very, very interesting:
http://www. style='background-color:yellow;'>pvct.com/inthenews.html?article=20111012&mode=0.
Journal of Surgical Oncology Articles Cover PV-10
October 12, 2011
Two recent papers published in volume 104 issue 4 of the Journal of Surgical Oncology cover the positive results seen in clinical studies of intralesional PV-10 for metastatic melanoma. The first article, titled "Local and Intralesional Therapy of In-Transit Melanoma Metastases", (page 392) reports excellent clinical results for intralesional Rose Bengal (PV-10) and evidence that PV-10 promotes a specific anti-tumor immune system response.
The second paper, titled "Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma", (pages 433-434), reports that PV-10 appears to be a powerful agent for local destruction of a number of tumor types with relatively few systemic side effects. The Journal of Surgical Oncology articles may be viewed at the below links.
Local and Intralesional Therapy of In-Transit Melanoma Metastases
Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma
PVCT - MUST read (cancer drug):
Very, very interesting:
http://www. style='background-color:yellow;'>pvct.com/inthenews.html?article=20111012&mode=0.
Journal of Surgical Oncology Articles Cover PV-10
October 12, 2011
Two recent papers published in volume 104 issue 4 of the Journal of Surgical Oncology cover the positive results seen in clinical studies of intralesional PV-10 for metastatic melanoma. The first article, titled "Local and Intralesional Therapy of In-Transit Melanoma Metastases", (page 392) reports excellent clinical results for intralesional Rose Bengal (PV-10) and evidence that PV-10 promotes a specific anti-tumor immune system response.
The second paper, titled "Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma", (pages 433-434), reports that PV-10 appears to be a powerful agent for local destruction of a number of tumor types with relatively few systemic side effects. The Journal of Surgical Oncology articles may be viewed at the below links.
Local and Intralesional Therapy of In-Transit Melanoma Metastases
Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma
ECDC monster run coming with TWITTER CEO coming on board
ECDC monster run coming with TWITTER CEO coming on board
PVCT - MUST read (cancer drug):
Very, very interesting:
http://www.pvct.com/inthenews.html?article=20111012&mode=0.
Journal of Surgical Oncology Articles Cover PV-10
October 12, 2011
Two recent papers published in volume 104 issue 4 of the Journal of Surgical Oncology cover the positive results seen in clinical studies of intralesional PV-10 for metastatic melanoma. The first article, titled "Local and Intralesional Therapy of In-Transit Melanoma Metastases", (page 392) reports excellent clinical results for intralesional Rose Bengal (PV-10) and evidence that PV-10 promotes a specific anti-tumor immune system response.
The second paper, titled "Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma", (pages 433-434), reports that PV-10 appears to be a powerful agent for local destruction of a number of tumor types with relatively few systemic side effects. The Journal of Surgical Oncology articles may be viewed at the below links.
Local and Intralesional Therapy of In-Transit Melanoma Metastases
Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma
PVCT - MUST read (cancer drug):
Very, very interesting:
http://www.pvct.com/inthenews.html?article=20111012&mode=0.
Journal of Surgical Oncology Articles Cover PV-10
October 12, 2011
Two recent papers published in volume 104 issue 4 of the Journal of Surgical Oncology cover the positive results seen in clinical studies of intralesional PV-10 for metastatic melanoma. The first article, titled "Local and Intralesional Therapy of In-Transit Melanoma Metastases", (page 392) reports excellent clinical results for intralesional Rose Bengal (PV-10) and evidence that PV-10 promotes a specific anti-tumor immune system response.
The second paper, titled "Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma", (pages 433-434), reports that PV-10 appears to be a powerful agent for local destruction of a number of tumor types with relatively few systemic side effects. The Journal of Surgical Oncology articles may be viewed at the below links.
Local and Intralesional Therapy of In-Transit Melanoma Metastases
Current and Planned Multicenter Trials for Patients With Primary or Metastatic Melanoma
ECDC - when the 8k comes out, u will wish u listened to me.
ECDC - when the 8k comes out, u will wish u listened to me.
ECDC ut and bid building - TWITTER CEO comong on board (via acquisition of Rogue Paper). When the 8k is filled - which could be anytime - this one will be a "shocker".
ECDC ut and bid building - TWITTER CEO comong on board (via acquisition of Rogue Paper). When the 8k is filled - which could be anytime - this one will be a "shocker".
AFPW assets of 0.16 $ per share !!!! AND the military contract now.....
AFPW assets of 0.16 $ per share !!!! AND the military contract now.....